Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Multicentre, Multiple-dose, Enriched Enrolment, Randomized-withdrawal, Parallel-group Phase III Study With Lido-Patch and Corresponding Placebo Plaster in Patients Suffering From Postherpetic Neuralgia (PHN)

NCT03745404 is registered in ClinicalTrials.gov with Grünenthal GmbH as lead sponsor.

NCT NCT03745404
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03745404 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Multicentre, Multiple-dose, Enriched Enrolment, Randomized-withdrawal, Parallel-group Phase III Study With Lido-Patch and Corresponding Placebo Plaster in Patients Suffering From Postherpetic Neuralgia (PHN)
Lead sponsor
Grünenthal GmbH
Phase
Phase 3
Overall status
Completed
Start date
April 29, 2003
Completion date
June 30, 2004
Enrollment
265 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

post herpetic neuralgia